Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

No reliable risk factors found for CA-MRSA

08.02.2007
Close contacts may have a higher likelihood of infection

In a continuing effort to improve the clinical management of community-acquired methicillin-resistant staphylococcus aureas (CA-MRSA), Loren Miller, M.D., M.P.H. and colleagues at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) found no reliable epidemiological or clinical risk factors that could distinguish patients with CA-MRSA infection from patients with CA-MSSA infection.

They suggest that, in settings where CA-MRSA is common, all patients with suspected CA S. aureus infection be placed in contact isolation and given appropriate therapy until the pathogens are identified. "What this means", says Dr. Miller, "is that the average Joe or Jane can get CA-MRSA. A person doesn't have to be special to get CA-MRSA. So a physician who thinks their patient with a skin infection is unlikely to have CA-MRSA because they haven't been to jail or use illicit drugs is apt to be wrong over half of the time." The research findings appear in the February 15, 2007 edition of Clinical Infectious Diseases.

In a separate article published in the same journal, Miller ands his colleagues investigated the outcomes for patients with either CA-MRSA or CA-MSSA skin infection 30 and 120 days after diagnosis. Despite the common belief that patients with CA-MRSA skin infection have more-serious outcomes than do patients with CA-MSSA infection, the authors found similar outcomes in the two groups. However, CA-MRSA infections are widely believed to be more transmissible than CA-MSSA infection. The authors also found data that close contacts of persons with CA-MRSA infection may have a higher likelihood of acquiring an infection than those with CA-MSSA. This observation supports the notion that CA-MRSA strains are more highly transmissible than the "old-fashioned" S. aureus, or CA-MSSA, strains.

... more about:
»CA-MRSA »CA-MSSA »aureus »risk factor

CA-MRSA is a methicillin-resistant Staphylococcus aureus infection, first recognized in the 1980s. Traditionally MRSA infections have been associated with hospitalization or other healthcare-associated risk factors, but in recent years, physicians and other healthcare providers have observed an increasing number of people with MRSA infections who lack traditional healthcare-associated risk factors. These people appear to have community-associated infections. Most infections caused by Staphylococcus aureus are skin and soft tissue infections such as abscesses or cellulitis. CA-MRSA is the most common cause of skin infection in many locales in the U.S., including Southern California. CA-MRSA strains are notable for their ability to spread in closed settings and cause recurrent infections among healthy persons.

These findings continue a series of investigations and research into CA-MRSA with data from the Los Angeles area. In findings published in February 2005 in The New England Journal of Medicine, Dr. Miller reviewed records of more than 800 patients whose wound cultures grew MRSA in the Los Angeles area from January 2003 to April 2004. 14 people were identified with necrotizing fasciitis, informally known as "flesh-eating bacteria," over a 14-month stretch through April 2004. As a result, physicians have been instructed that if they see cases of necrotizing fasciitis, they are to treat for the resistant bug in addition to the other known causes until they know the causative bacterial.

Dr. Miller and his colleagues in LA BioMed's Division of Infectious Disease have a reputation for examining cutting-edge issues. For example:

In a seminal article titled "Trends in Antimicrobial Drug Development: Implications for the Future" published in 2004, Brad Spellberg, MD and his colleagues reported that the need for new antimicrobial agents is greater than ever because of the emergence of multidrug resistance in common pathogens, the rapid emergence of new infections, and the potential for use of multidrug-resistant agents in bioweapons. They determined that FDA approval of new antibacterial agents decreased by 56% from 1998 to 2002. Spellberg's article became the basis of a July 2004 report by The Infectious Diseases Society of America (IDSA) titled "Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, a Public Health Crisis Brews." Many if not all of the frightening conclusions in that report continue to be valid today.

Candida albicans and its related candidal species have emerged as the fourth most common organism recovered in blood cultures in hospitalized patients and carry an attributable mortality rate of 38%, even when treatment with currently available antifungals is used. Dr. John E. Edwards, Jr. and colleagues at LA BioMed have determined that the gene ALS1 in Candida encodes a protein (A1s1p), an important cell surface adhesion responsible for the attachment of the organism to human cells. The Edwards team has found that vaccination of mice with A1s1p protein protects against intravenous inoculations of C. albicans. They have developed a molecular biological approach to efficiently discover new cell wall proteins that may be adhesions and become future vaccine candidates. They have also developed the technology to couple selected proteins of interest to selected carbohydrate antigens in the candidal cell wall. The combined protein/carbohydrate antigens may have enhanced antigenicity.

Michael Yeaman, MSc, PhD, Professor of Medicine with the Department of Medicine/Infectious Diseases, has been appointed to serve as a member of the Host Interactions with Bacterial Pathogens Study Section (HIBP), Center for Scientific Review (CSR). The HIBP reviews applications involving studies that focus on bacterial factors that alter/affect host cells, or the host aspect of the host pathogen interaction. Dr. Yeaman's appointment to the study section is an indication of how highly his research is regarded by his peers in the field of infectious diseases. Dr. Yeaman has focused his research on the relationship between microbial pathogenesis and host defense. He has studied the mechanisms of intracellular killing of microbial pathogens by macrophages and neutrophils, the structures and mechanisms of action of antibiotics and antimicrobial peptides, the role of virulence factors in pathogenesis of infections, and the interactions between bacterial and fungal pathogens with eukaryotic cells.

David Feuerherd | EurekAlert!
Further information:
http://www.rei.edu/

Further reports about: CA-MRSA CA-MSSA aureus risk factor

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>